IRCT201202106302N2已完成3 期
Efficacy analysis of Recombinant factor VIIa (Aryogen) in Comparison with Novoseven® on patients with congenital hemophilia A/B with inhibitors
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 80 years（—）
- 性别
- All
入选标准
- •known case of congenital hemophilia A/B with inhibitors level more than 5 Bethesda unit, age older than 2 , gender male or female, proper IV line for drug injection, the severity of bleeding should be evaluable Exclusion criteria: Presence of any congenital or acquired coagulopathy disorders except for congenital hemophilia A/B with inhibitors such as:( liver disease (hepatitis), uremia, malignancy, vitamin K deficiency) , severe atherosclerotic disease, any local pathology that predisposes the patient to bleeding, having been under immune tolerance induction therapy during one month prior to the study, Platelet count lower than 50000
排除标准
- 未提供
研究者
相似试验
已完成
3 期
The comparison of efficacy between Novoseven® and Recombinant factor VIIa (Aryogen)congenital FVII deficiency.Hereditary deficiency of other clotting factorsIRCT201104266302N1AryoGen Biopharma Company66
已完成
3 期
Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation ActivationHemophilia ANCT00375323Medical University of Vienna
进行中（未招募）
不适用
Efficacy and safety of factor VIIa eptacog alfa, Novoseven on rebleeding after surgery for spontaneous supratentorial intracerebral, hemorrhage. A randomized, controlled, open-label, investigator-blinded pilot study.EUCTR2005-003083-36-ITOSPEDALE POLICLINICO S. MATTEO
进行中（未招募）
1 期
Recombinant Factor VIIa: Local treament of severe bleedings after deliverySevere postpartum bleedingMedDRA version: 16.1Level: LLTClassification code 10071867Term: Postpartum bleedingSystem Organ Class: 100000004868MedDRA version: 16.1Level: LLTClassification code 10071897Term: Third stage postpartum bleedingSystem Organ Class: 100000004868EUCTR2013-005036-20-DKStellaris Pharmaceuticals ApS
已完成
3 期
Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major BurnBurnsNCT00243243United States Army Institute of Surgical Research20